201 related articles for article (PubMed ID: 1686717)
1. The role of P-glycoprotein in drug-resistant hematologic malignancies.
Dalton WS; Grogan TM; Miller TP
Cancer Treat Res; 1991; 57():187-208. PubMed ID: 1686717
[No Abstract] [Full Text] [Related]
2. Multidrug resistance in human cancer.
Goldstein LJ; Pastan I; Gottesman MM
Crit Rev Oncol Hematol; 1992; 12(3):243-53. PubMed ID: 1353966
[No Abstract] [Full Text] [Related]
3. Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.
Dalton WS; Grogan TM; Meltzer PS; Scheper RJ; Durie BG; Taylor CW; Miller TP; Salmon SE
J Clin Oncol; 1989 Apr; 7(4):415-24. PubMed ID: 2564428
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance (MDR) genes in haematological malignancies.
Nooter K; Sonneveld P
Cytotechnology; 1993; 12(1-3):213-30. PubMed ID: 7765326
[TBL] [Abstract][Full Text] [Related]
5. Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer.
Salmon SE; Dalton WS; Grogan TM; Plezia P; Lehnert M; Roe DJ; Miller TP
Blood; 1991 Jul; 78(1):44-50. PubMed ID: 1676918
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein expression in bladder cancer.
Park J; Shinohara N; Liebert M; Noto L; Flint A; Grossman HB
J Urol; 1994 Jan; 151(1):43-6. PubMed ID: 7902877
[TBL] [Abstract][Full Text] [Related]
7. Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assay.
Zhan Z; Sandor VA; Gamelin E; Regis J; Dickstein B; Wilson W; Fojo AT; Bates SE
Blood; 1997 May; 89(10):3795-800. PubMed ID: 9160686
[TBL] [Abstract][Full Text] [Related]
8. [The pleiotropic drug resistance phenotype: role of reverting agents "in vitro" and "in vivo"].
Petrini M; Carulli G; Mattii L; Sabbatini A; Pardi C; Caracciolo F; Grassi B
Haematologica; 1991 Jun; 76 Suppl 3():173-6. PubMed ID: 1684344
[No Abstract] [Full Text] [Related]
9. [Tumor resistance to multiple antineoplastic agents mediated by glycoprotein P: from the laboratory to the clinical field].
González-Manzano R
Med Clin (Barc); 1994 Apr; 102(13):506-15. PubMed ID: 7911549
[No Abstract] [Full Text] [Related]
10. Multidrug resistance in leukemia.
Rischin D; Ling V
Cancer Treat Res; 1993; 64():269-93. PubMed ID: 8095795
[No Abstract] [Full Text] [Related]
11. A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study.
Dalton WS; Crowley JJ; Salmon SS; Grogan TM; Laufman LR; Weiss GR; Bonnet JD
Cancer; 1995 Feb; 75(3):815-20. PubMed ID: 7828131
[TBL] [Abstract][Full Text] [Related]
12. Modulators of P-glycoprotein-associated multidrug resistance.
Beck WT
Cancer Treat Res; 1991; 57():151-70. PubMed ID: 1686715
[No Abstract] [Full Text] [Related]
13. Clinical trials of agents that reverse multidrug-resistance.
Gottesman MM; Pastan I
J Clin Oncol; 1989 Apr; 7(4):409-11. PubMed ID: 2564427
[No Abstract] [Full Text] [Related]
14. Response of a multidrug-resistant human small-cell lung cancer xenograft to chemotherapy.
Arvelo F; Poupon MF; Goguel AF; Lizard G; Bourgeois Y; Arriagada R; Le Chevalier T
J Cancer Res Clin Oncol; 1993; 120(1-2):17-23. PubMed ID: 7903668
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance: P-glycoprotein and its allies--the elusive foes.
Chabner BA; Fojo A
J Natl Cancer Inst; 1989 Jun; 81(12):910-3. PubMed ID: 2567356
[No Abstract] [Full Text] [Related]
16. MDR-1 expression and response to vincristine, doxorubicin, and dexamethasone chemotherapy in multiple myeloma refractory to alkylating agents.
Cornelissen JJ; Sonneveld P; Schoester M; Raaijmakers HG; Nieuwenhuis HK; Dekker AW; Lokhorst HM
J Clin Oncol; 1994 Jan; 12(1):115-9. PubMed ID: 7903690
[TBL] [Abstract][Full Text] [Related]
17. Expression of the MDR1 gene in human cancers.
Goldstein LJ; Gottesman MM; Pastan I
Cancer Treat Res; 1991; 57():101-19. PubMed ID: 1686712
[No Abstract] [Full Text] [Related]
18. [Multidrug resistance].
Baccarani M
Haematologica; 1991 Jun; 76 Suppl 3():145-9. PubMed ID: 1684337
[No Abstract] [Full Text] [Related]
19. Multidrug resistance: clinical relevance in haematological malignancies.
Kaye SB; Kerr DJ
Blood Rev; 1991 Mar; 5(1):38-41. PubMed ID: 1674435
[TBL] [Abstract][Full Text] [Related]
20. Differential over-expression of mdr1 genes in multidrug-resistant rat glioblastoma cell lines selected with doxorubicin or vincristine.
Schott B; Bennis S; Pourquier P; Ries C; Londos-Gagliardi D; Robert J
Int J Cancer; 1993 Aug; 55(1):115-21. PubMed ID: 8102127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
